Author:
Malucchi Simona,Gilli Francesca,Caldano Marzia,Sala Arianna,Capobianco Marco,Sapio Alessia,Granieri Letizia,Bertolotto Antonio
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference40 articles.
1. Malucchi S, Gilli F, Caldano M, Marnetto F, Valentino P, Granieri L, Sala A, Capobianco M, Bertolotto A (2008) Predictive markers for response to interferon therapy in patients with multiple sclerosis. Neurology 70(13 Pt 2):119–127
2. Gilli F, Marnetto F, Caldano M et al (2005) Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. J Neuroimmunol 158:195–203
3. Gilli F, Marnetto F, Caldano M et al (2006) Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. Mult Scler 12:47–57
4. Deisenhammer F, Reindl M, Harvey J, Gasse T, Dilitz E, Berger T (1999) Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies. Neurology 52:1239–1243
5. Vallittu AM, Halminen M, Peltoniemi J, The Finnish Beta-Interferon Study Group et al (2002) Neutralizing antibodies reduce MxA protein induction in interferon beta-1a-treated MS patients. Neurology 58:1786–1790
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献